Abstract:Introduction: Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) are critical components of the extracellular matrix (ECM) in colorectal cancer (CRC). We aimed to evaluate the prognostic value of MMP-2 and MMP-9 in patients with CRC. Methods: We performed a meta-analysis of cohort studies with available data on the effect of MMP-2 and MMP-9 expression on both disease-free survival (DFS) and overall survival (OS) by the risk ratios (RRs) with their 95% confidence intervals (CIs). Studies were subgrouped based on the different tissue types, including cancer tissue and normal tissue, and the subgroup effect of MMP expression in different tissues was analyzed through meta-regression. To ensure the quality and reduce the risk of bias, the Newcastle‒Ottawa Scale (NOS) was used to assess the included studies. A sensitivity analysis was randomly performed to assess the potential impact of each study on our results. Results: Eighteen trials were selected (Table 1) and included a total of 3944 patients. According to our primary meta-analysis, the expression of MMP-2 was significantly associated with a decrease in OS (RR = 1.75, 95% CI = 1.34 to 2.29, P < 0.001) and DFS (RR = 2.62, 95% CI = 1.25 to 5.49, P < 0.001), and the expression of MMP-9 was not significantly associated with a decrease in OS (RR = 1.48, 95% CI = 0.97 to 2.24, P = 0.069) or DFS (RR = 1.60, 95% CI = 0.87 to 2.94, P = 0.133). According to the subgroup analysis of MMPs in different tissues, high MMP-2 expression in cancer tissue (RR = 1.90, 95% CI = 1.29 to 2.79) and normal tissue (RR = 1.59, 95% CI = 1.17 to 2.17) were significant indicators of poor OS. High MMP-2 expression in cancer tissue was significant indicator of poor DFS (RR = 2.12, 95% CI = 1.09 to 4.11). MMP-9 expression was also associated with poor OS (RR = 1.40, 95% CI = 0.85 to 2.29), but the difference in OS between the high and low expression groups was not statistically significant. Conclusions: High MMP-2 expression, especially in cancer tissue, is significantly associated with both poor DFS and poor OS in patients with CRC. High MMP-9 expression tended to indicate a poor prognosis of CRC but the correlation was not significant.

Elevated Serum Levels Of Mmp-11 Correlate With Poor Prognosis In Colon Cancer Patients

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

Prognostic Significance of Matrix Metalloproteinase 7 Immunohistochemical Expression in Colorectal Cancer: a Meta-Analysis.

Matrix Metalloproteinase-9 Overexpression is Closely Related to Poor Prognosis in Patients with Colon Cancer

Prognostic significance of the matrix metalloproteinase-11 expression in tumor cells in invasive ductal carcinoma of the breast

Prognostic significance of matrix metalloproteinase-1 levels in peripheral plasma and tumour tissues of lung cancer patients

Expression of MMP-11 in Serum of Gastric Cancer and Its Significance

Identification of high-risk stage II and stage III colorectal cancer by analysis of MMP-21 expression.

Identification of Matrix Metalloproteinase 11 As a Predictive Tumor Marker in Serum Based on Gene Expression Profiling.

Prognostic Significance of Matrix Metalloproteinase 14 in Patients with Cancer: a Systematic Review and Meta-Analysis

Expression of CD147 and Matrix Metalloproteinase-11 in Colorectal Cancer and Their Relationship to Clinicopathological Features.

MMP11 as a prognostic biomarker correlated with immune infiltrates in pancreatic adenocarcinoma

Expression of matrix metalloproteinase 1 in tissue of colon carcinoma and its clinical prognostic significance

Mmp-14 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer

Matrix Metalloproteinase 11 Promotes Migration and Invasion of Colorectal Cancer by Elevating Slug Protein

Clinical significance of serum matrix metalloproteinases - 7 in patients with colorectal carcinoma

Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.

Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer

Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis

Tumor Epithelial Cell MMP-9 is a Prognostic Marker in Colorectal Cancer

Pan-cancer Analysis Reveals the Associations Between MMP13 High Expression and Carcinogenesis and Its Value As a Serum Diagnostic Marker.